MORGAN HOFFMAN: Open Payments
NPI 1467044669 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,538 in 145 payments from 18 companies in 2025. Trend: 2023 $3,215 · 2024 $4,807 · 2025 $3,538
Food & beverage: $3,439Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $853 |
| Amgen Inc. | 18 | $410 |
| Novartis Pharmaceuticals Corporation | 15 | $374 |
| GlaxoSmithKline, LLC. | 9 | $354 |
| PFIZER INC. | 16 | $295 |
| AstraZeneca Pharmaceuticals LP | 7 | $238 |
| UCB, Inc. | 13 | $201 |
| Janssen Biotech, Inc. | 5 | $200 |
| Mallinckrodt Hospital Products Inc. | 8 | $191 |
| GENZYME CORPORATION | 5 | $131 |
Products named: RINVOQ, COSENTYX, TREMFYA, SAPHNELO, SKYRIZI, Bimzelx, ACTHAR, OCTAGAM IMMUNE GLOBULIN (HUMAN).
Industry payments across LA — which companies pay providers there.
